Since November 2018 clinicians can prescribe cannabis-centered solutions for medicinal use (CBPMs), but NHS prescriptions are tightly controlled and comparatively unusual. Standard instances where CBPMs is likely to be regarded consist of intense, treatment method-resistant epilepsy and some pain/spasticity ailments — and even then it usually nee